Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Coloplast A/S    COLO B   DK0060448595

COLOPLAST A/S (COLO B)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
09/17/2018 09/18/2018 09/19/2018 09/20/2018 09/21/2018 Date
663.6(c) 655.2(c) 651(c) 655(c) 651.2 Last
204 653 451 499 281 227 211 938 262 978 Volume
-1.54% -1.27% -0.64% +0.61% -0.58% Change
More quotes
Financials (DKK)
Sales 2018 16 580 M
EBIT 2018 5 104 M
Net income 2018 3 887 M
Debt 2018 1 224 M
Yield 2018 2,38%
Sales 2019 17 994 M
EBIT 2019 5 623 M
Net income 2019 4 298 M
Debt 2019 1 115 M
Yield 2019 2,58%
P/E ratio 2018 35,59
P/E ratio 2019 32,07
EV / Sales2018 7,90x
EV / Sales2019 7,27x
Capitalization 130 B
More Financials
Company
Coloplast A/S develops, manufactures, and markets medical products.It operates through the following segments: Chronic Care; Urology Care; and Wound and Skin Care.The Chronic Care segment covers the sale of ostomy care products and continence care products.The Urology Care segment covers the sale... 
More about the company
Surperformance© ratings of Coloplast A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on COLOPLAST A/S
09/20BIOTEC PHARMACON : changes management in the wound care area
AQ
09/18COLOPLAST A/S : Annonucement no. 7/2018 - Coloplast Capital Markets Day 2018
AQ
09/06COLOPLAST A/S : "Penile Prosthesis Kit Of Parts" in Patent Application Approval ..
AQ
08/24COLOPLAST A/S : Announcement no. 6/2018 - Financial calendar 2018/19
AQ
08/22COLOPLAST A/S : Trading in Coloplast shares by board members, executives or asso..
AQ
08/16COLOPLAST A/S : "Inflatable Penile Prosthetic System" in Patent Application Appr..
AQ
08/09COLOPLAST A/S : Patent Issued for Hysteropexy Mesh Apparatuses And Methods (USPT..
AQ
08/08COLOPLAST A/S : Class B to Host Earnings Call
AC
08/08COLOPLAST A/S : Announcement no. 5/2018 - Interim Financial Report, 9M 2017/18
AQ
08/08COLOPLAST A/S : 3rd quarter results
CO
More news
Sector news : Medical Equipment Wholesale
09/21Disruption to medical business takes toll on Smiths Group
RE
09/21MAZOR ROBOTICS : Medtronic to acquire Mazor in $1.64 billion deal
RE
09/21MEDTRONIC : to Acquire Mazor Robotics for $1.64 Billion
DJ
09/13Smiths and ICU Medical healthcare merger talks collapse
RE
09/11STRYKER : to Buy Invuity for About $190 Million
DJ
More sector news : Medical Equipment Wholesale
Latest Tweets
09/20$COLO B #Coloplast A/S Series B, ... Northern Lights: |  
09/19$COLO B A/S Series B, Coloplast (Buy, TP: DKK745.00) - Sustainable high orga.. 
09/17$COLO B A/S Series B, Coloplasts steady stream of innovation has allowed the.. 
09/17$COLO B A/S Series B, Morningstar | Coloplasts steady stream of innovation h.. 
09/10$COLO B #Coloplast A/S Series B, ... Northern Lights: |  
More tweets
Qtime:29
News from SeekingAlpha
08/11Coloplast ASB (CLPBF) CEO Lars Rasmussen on Q2 2018 Results - Earnings Call T.. 
08/08Coloplast ASB 2018 Q3 - Results - Earnings Call Slides 
08/08Coloplast ASB misses by DKK0.31, misses on revenue 
06/21Coloplast (CLPBY) Presents At Deutsche Bank H1 2017/18 Roadshow - Slideshow 
05/07Coloplast's (CLPBF) CEO Lars Rasmussen on Q2 2018 Results - Earnings Call Tra.. 
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Average target price 619  DKK
Spread / Average Target -5,6%
EPS Revisions
Managers
NameTitle
Lars Søren Rasmussen President & Chief Executive Officer
Michael Pram Rasmussen Chairman
Allan Rasmussen Executive Vice President-Global Operations
Anders Lonning-Skovgaard Chief Financial Officer & Executive Vice President
Oliver Johansen Senior VP-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
COLOPLAST A/S32.73%20 491
HENRY SCHEIN20.89%13 149
AMPLIFON SPA51.25%5 179
CANTEL MEDICAL CORP.-5.38%4 075
MERIT MEDICAL SYSTEMS, INC.40.74%3 339
PATTERSON COMPANIES-29.59%2 418